Multi-nucleated giant cell formation from human cord blood monocytes in vitro, in comparison with adult peripheral blood monocytes
Related Experiment Video
Updated: Jun 20, 2026

Pan-myeloid Differentiation of Human Cord Blood Derived CD34+ Hematopoietic Stem and Progenitor Cells
Published on: August 9, 2019
1Department of Pediatrics, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences 2-5-1 Shikata-cho, Okayama, Japan.
Abstract:
Multi-nucleated giant cells (MGCs; Langhans-type cell), formed from macrophage fusion, are recognized as a hallmark histological feature in chronic inflammation. However, their precise pathological role is still poorly understood, especially for microorganism pathogens in the neonatal immune system, which are capable of surviving intracellularly in phagocytes. To conduct a partial evaluation of the monocyte function of neonates, we investigated the ability of human cord blood monocytes to form MGCs in vitro by stimulating various cytokines and comparing them with adult peripheral blood monocytes. Monocytes from cord blood and adult peripheral blood were isolated and cultured for 14 days with cytokines known to induce MGC in vitro. The fusion index in experiments with a combination of interleukin (IL)-4 and macrophage colony-stimulating factor (M-CSF) and a combination of IL-4 and granulocyte-macrophage colony-stimulating factor (GM-CSF) was significantly lower in cord blood than in adult blood monocytes (P = 0.0018 and P = 0.0141, respectively). The number of nuclei per MGC was significantly lower in cord blood than in adult blood monocytes in experiments with IL-4 alone, the combination of IL-4 and M-CSF, and the combination of IL-4 and GM-CSF (P < 0.0001). These results suggest the possibility that the susceptibility of newborns to mycobacterium infection is due partly to impaired MGC formation.
Insights
Newborn monocytes form fewer multi-nucleated giant cells (MGCs) compared to adults. This impaired MGC formation may contribute to infant susceptibility to infections like mycobacterium.
Area of Science:
- Immunology
- Cell Biology
- Neonatal Health
Background:
- Multi-nucleated giant cells (MGCs), formed from fused macrophages, are key in chronic inflammation.
- Their role in neonatal immunity, especially against intracellular pathogens, is not fully understood.
- Neonates exhibit increased susceptibility to certain infections, potentially linked to immune cell function.
Purpose of the Study:
- To evaluate the in vitro MGC-forming capacity of human neonatal monocytes.
- To compare MGC formation between cord blood (neonatal) and adult peripheral blood monocytes.
- To investigate the influence of specific cytokines on monocyte fusion in neonates versus adults.
Main Methods:
- Isolation and culture of monocytes from human cord blood and adult peripheral blood.
- Stimulation of monocytes with various cytokines (e.g., IL-4, M-CSF, GM-CSF) for 14 days.
- Quantification of MGC formation using fusion index and nuclei count per MGC.
Main Results:
- Cord blood monocytes showed significantly lower MGC fusion index with IL-4/M-CSF and IL-4/GM-CSF combinations compared to adult monocytes.
- The number of nuclei per MGC was significantly reduced in cord blood monocytes across multiple cytokine treatments (IL-4 alone, IL-4/M-CSF, IL-4/GM-CSF).
- These findings indicate an impaired ability of neonatal monocytes to form MGCs in vitro.
Conclusions:
- Neonatal monocytes exhibit reduced MGC formation capacity compared to adult monocytes.
- Impaired MGC formation in neonates may be a contributing factor to their increased susceptibility to intracellular pathogens.
- Further research into neonatal immune cell function is crucial for understanding and managing infant infections.
More Related Videos
09:46Megakaryocyte Differentiation and Platelet Formation from Human Cord Blood-derived CD34+ Cells
Published on: December 27, 2017
09:20Differentiation of Monocytes into Phenotypically Distinct Macrophages After Treatment with Human Cord Blood Stem Cell (CB-SC)-Derived Exosomes
Published on: November 12, 2020